Atorvastatin attenuates Lrp5/Wnt-mediated atherosclerosis and osteoporosis in a mouse model of experimental hypercholesterolemia.

被引：0
|
作者：
Rajamannan, N. M. [1 ]
Subramaniam, M. [1 ]
Caira, F. C. [1 ]
Stock, S. [1 ]
Hefferan, T. [1 ]
Flores, A. [1 ]
Spelsberg, T. C. [1 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2007年 / 55卷 / 02期
关键词：
D O I：
10.1097/00042871-200703010-00066
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
59
引用
收藏
页码：S358 / S358
页数：1
相关论文
共 11 条
  • [1] Atorvastatin attenuates vascular glomeruli atherosclerosis in experimental hypercholesterolemia.
    Gallagher, P
    Le, TA
    Pandya, S
    McConnell, J
    Singh, R
    Caira, F
    Gocek, L
    Subramaniam, M
    Spelsberg, TC
    Rajamannan, NM
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (02) : S364 - S364
  • [2] Atorvastatin inhibits lipid induced aortic valve calcification and osteoporosis via the Lrp5/Wnt mediated pathways in vivo and in vitro
    Rajamannan, N. M.
    Caira, F. C.
    Flores, A. L.
    Dolehide, C. P.
    Arterburn, L. B.
    Subramaniam, M.
    Spelsberg, T. C.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S44 - S44
  • [3] Atorvastatin Attenuates Lrp5 Mediated Calcification in the Hypercholesterolemic Aortic Valves from ApoE mice
    Kruger, Bryan Mathew
    Stock, Stuart R.
    Rajamannan, Nalini M.
    FASEB JOURNAL, 2009, 23
  • [4] Atorvastatin inhibits hypercholesterolemia-induced glomerular proliferation and matrix production via the Lrp5/Wnt pathway
    Manca, Tullio
    Caira, Frank C.
    Flores, Amy L.
    Rajamannan, Nalini M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 51 (10) : A295 - A295
  • [5] Atorvastatin inhibits Lrp5/Wnt mediated in vitro aortic valve cell proliferation and bone matrix production
    Rajamannan, NM
    Caira, F
    Subramaniam, M
    Spelsberg, TC
    CIRCULATION, 2004, 110 (17) : 709 - 709
  • [6] Atorvastatin inhibits hypercholesterolemia-induced proliferation and extracellular matrix production in the renal glomeruli via the Wnt/Lrp5 receptor pathway
    Caira, F. C.
    Manca, T.
    Rajamannah, N. M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (03) : 651 - 652
  • [7] Wnt-mediated signaling via LRP5 and beta-catenin induce osteoblast differentiation and mediates the effects of BMP2.
    Roman, SR
    Vayssière, B
    Shi, D
    Dunn, F
    Baron, R
    Rawadi, G
    JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S126 - S126
  • [8] Atorvastatin attenuates Lrp5-mediated aortic valve calcification and osteoporosis in LDLR-/- hypercholesterolemic mice
    Rajamannan, Nalini
    Calra, Frank C.
    Subramaniam, Malayarman
    Stock, Stuart
    Flores, Amy
    Spelsberg, Thomas C.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E76 - E76
  • [9] Cytoprotective effects of C1s enzyme in macrophages in atherosclerosis mediated through the LRP5 and Wnt/β-catenin pathway
    Yuan, Dong
    Zheng, Zhipeng
    Shen, Cheng
    Ye, Jun
    Zhu, Li
    MOLECULAR IMMUNOLOGY, 2024, 166 : 29 - 38
  • [10] Inhibition of LRP5/6-mediated Wnt/β-catenin signaling by Mesd attenuates hyperoxia-induced pulmonary hypertension in neonatal rats
    Deepthi Alapati
    Min Rong
    Shaoyi Chen
    Cuihong Lin
    Yonghe Li
    Shu Wu
    Pediatric Research, 2013, 73 : 719 - 725
12